Essential oils | СС50 *)(mg/mL, ± SD) | Concentrations (mg/mL) | Antiviral activity | |||||
---|---|---|---|---|---|---|---|---|
Pre-treatment of cells | IC50(mg/ml) | SI | Pre-treatment of virus | IC50(mg/ml) | SI | |||
E. cin | 204.5 ± 0.35b•) | 150 | 66.5 | 131b | 1.56a | 71 | 102c | 2a |
75 | 0 | 54 | ||||||
37.5 | 0 | 0 | ||||||
E. sid | 247.3 ± 0.9c | 150 | 0 | Nd | Nd | 0 | Nd | Nd |
75 | 0 | 0 | ||||||
37.5 | 0 | 0 | ||||||
E. mai | 253.5 ± 0.35c | 150 | 29 | 233.5c | 1.08a | 62.5 | 136.5d | 1.85a |
75 | 0 | 0 | ||||||
37.5 | 0 | 0 | ||||||
E. leh | 15 ± 00.0a | 15 | 0 | Nd | Nd | 0 | Nd | Nd |
7.5 | 0 | 0 | ||||||
3.75 | 0 | 0 | ||||||
E. bic | 16 ± 00.0a | 15 | 0 | 4.8a | 3.33b | 0 | 0.7a | 22.8b |
7.5 | 66.5 | 87.5 | ||||||
3.75 | 37.5 | 83 | ||||||
E. ast | 15.7 ± 0.14a | 15 | 0 | Nd | Nd | 83 | 8.4b | 1.86a |
7.5 | 0 | 46 | ||||||
3.75 | 0 | 25 | ||||||
E. leu | 14.9 ± 0.07a | 15 | 0 | Nd | Nd | 0 | Nd | Nd |
7.5 | 0 | 0 | ||||||
3.75 | 0 | 0 | ||||||
E. odo | 6.2 ± 0.14a | 6 | 0 | Nd | Nd | 0 | Nd | Nd |
3 | 0 | 0 | ||||||
 |  | 1.5 | 0 |  |  | 0 |  |  |